GlaxoSmithKline plc CEDEAR Logo

GlaxoSmithKline plc CEDEAR (GSKD)

BCBA

Currency in USD
12.35
+0.21 (+1.73%)

Real-time Data

02:00 PM

Day's Range

12.27
12.35

52 wk Range

10.99
15.96

Overview - GSKD - GlaxoSmithKline plc CEDEAR

Key Statistics

Valuation

Enterprise Value

54.53B

P/E (Trailing)

‪0.04‬

Price / Book

‪1.10‬

EV / EBITDA

‪3.79‬

Profitability

Profit Margin

‪14.52%‬

Operating Margin

‪30.94%‬

Return on Assets

‪10.00%‬

Return on Equity

‪33.38%‬

Ownership

Float

1.94B

Held by Insiders

‪0.00%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪0.29‬

50-Day Avg

‪13.27‬

200-Day Avg

‪13.44‬

Dividends

Frequency

Quarterly

News Teaser - GSKD - GlaxoSmithKline plc CEDEAR

News & Analysis

View all news

Peers - GSKD - GlaxoSmithKline plc CEDEAR

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on BCBA.

Profile Summary - GSKD - GlaxoSmithKline plc CEDEAR

About

GlaxoSmithKline plc CEDEAR is a depositary receipt representing shares of GlaxoSmithKline plc, a leading global pharmaceutical and healthcare company. CEDEARs (Certificados de Depósito Argentinos) enable Argentine investors to access foreign securities, allowing them to participate in the performance of major…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees66.84K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.